Diabetic Retinopathy (DR), an eye condition causing vision loss and blindness, affects ~16.9% of patients with Diabetes and 3.6% of whom are most likely to lose their vision because of sight-threatening DR (STDR).
Towards preventing needless blindness arising from DR, Remidio worked with the Directorate of Health Services (DHS), Government of Kerala, on project Nayanamritham, the brainchild of Dr. Sobha Sivaprasad, Professor and Consultant Ophthalmologist at Moorfields Eye Hospital, London, UK.
This video, created with the support of Dr. Bipin Gopal, Additional Health Secretary of Kerala, Shailaja Teacher, and Dr. Sobha Sivaparasad, is a visual testimonial of our impact in Kerala. At the same time, Remidio's Fundus on Phone, the world's first non-mydriatic smartphone-based portable fundus camera, powered the DR screening at the 16 Family Health Centres (FHCs) across the Thiruvananthapuram district.
The success of this program, wherein 1 in 3 patients with Diabetes were detected to have Retinopathy, and moved to the care pathway, paves the way for other states to implement similar cost-effective and accessible models for screening chronic eye diseases like DR.
More details on the study and its outcomes are in the link - [ Ссылка ]
Please write to us at marketing@remidio.com to know how, together, we can eradicate needless blindness in India.
* Note: Necessary approvals (including patient consent) have been procured before posting the video
We are equally active on other social media handles as well.
Do follow us.
Facebook - [ Ссылка ]
LinkedIn - [ Ссылка ]
Twitter - [ Ссылка ]
Instagram - [ Ссылка ]
Check our website to know more about us - www.remidio.com
